https://www.washingtonpost.com/health/2023/10/24/rsv-monoclonal-shortage-cdc-update/
The agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
Create an account or login to join the discussion